International PhD Program in Arterial Hypertension and Vascular Biology


The International PhD program in Arterial Hypertension and Vascular Biology is based in the Department of Medicine – DIMED of the University of Padua.  This is a referral centre for Arterial Hypertension and cardiovascular diseases in Italy and a Centre of Excellence for Hypertension Research of the European Society of Hypertension (ESH).

This programme is the first in Europe devoted to Hypertension research and was established in conjunction with the University of Rome La Sapienza, Italy, and the School for Cardiovascular Diseases in Maastricht (CARIM), The Netherlands.  It requires a rotation across the three Universities and possibly stages at other leading research centres in Europe and the US.

pagina su

  About the PhD Course

The PhD entails specific commitment and training in the following areas:

1. Experimental research

  • Vascular biology with emphasis on the endothelium and endothelial (dys)function, and its role in the control of vascular tone;
  • Salt and water homeostasis;
  • Pathophysiology of control of blood pressure;
  • Molecular analysis methodologies;
  • Experimental atherosclerosis;
  • Arterial hypertension from animal models;
  • Molecular and experimental pharmacology;
  • Pharmacokinetics and pharmacodynamics of anti-hypertensive medications.

2. Clinical research.

  • Epidemiology and statistics applied to hypertension;
  • Principles of pharmaco-economics applied to hypertension;
  • Methodologies for assessment of target organ damage in hypertension;
  • Pathophysiology of the secondary forms of hypertension;
  • Guidelines for risk stratification and treatment;
  • Design and planning of clinical trials in hypertension.


The First Year of Research

The student will do coursework and labwork.

The curriculum will involve:

  1. General research methods training. An introductory course is held every year at the Venetian Institute of Medicine (VIMM) by the Faculty members of all PhD Courses of the University of Padua and outside experts in scientific fields. The course is focused on ‘How to do research” and covers applications of chemistry and physics to Medicine, genetics, molecular biology, statistics, ethics and social aspects.
  2. Attendance at research workshops and seminars held by the Faculty members and PhD students or outside speakers, mostly focussed on the cardiovascular system.
  3. Advanced coursework in the laboratories. The PhD student has the chance to be educated at a variety of techniques and introduced to a wide array of inter-disciplinary and comprehensive cardiovascular disease programs.

At the end of the 1st year the PhD student is expected to have practised skills of organizing, structuring, and presenting research,  Hence, he/she will be assigned to a specific research project in the field of Arterial Hypertension and Vascular biology under the strict supervision of an experienced tutor. Whether 1st year PhD student is upgraded to PhD status at the end of the first year of research will depend on his/her performance in the curriculum.


Second and Third Years of Research

Once upgraded to the 2nd year PhD student status, the student will concentrate on his/her PhD labwork to prepare his/her final dissertation. As research progresses, there will be opportunities to present work in progress at research workshops attended by Faculty members and research students. The PhD student will have also the opportunity to attend Journal Club and the Weekly Meetings given by outside speakers and Faculty members.

At the 2nd or the 3rd year the PhD student will spend at least 6 months abroad, at the CARIM or in another lab that could be of interest for the ongoing research.

The normal deadline for submission of the dissertation will be the end of December in the third year of research. Within this time, an original work focussed on the assigned theme should have been completed and discussed in detail with the tutor. The defence will occur about 2 months after, at the presence of the Faculty members, including members from CARIM.

  Application and Admission

Call for admission to the PhD Courses 39° Cycle 2023/2024 and enrollment procedure:

English version:



  Coordinator and Faculty Staff


Gian Paolo Rossi


Faculty Staff

Giovanna Albertin, University of Padua, I 

Stefania Brozzetti, University of Rome La Sapienza, I 

Diego Cecchin, University of Padua, I

Giulio Ceolotto, University of Padua, I

Cristina Chimenti, University of Rome La Sapienza, I

Giancarlo D'ambrosio, University of Rome La Sapienza, I

Carolina De Ciuceis, University of Brescia, I

Franco Grego, University of Padua, I

Maurizio Iacobone, University of Padua, I

Claudio Letizia, University of Rome La Sapienza, I 

Sandro Mazzaferro, University of Rome La Sapienza, I

Mirko Menegolo, University of Padua, I

Raffaella Motta, University of Padua, I

Maria Lorenza Muiesan, University of Brescia, I

Elena Pacella, University of Rome La Sapienza, I

Andrea Padoan, University of Padua, I

Luigi Petramala, University of Rome La Sapienza, I

Stefano Piaserico, University of Padua, I

Gianfranco Piccirillo, University of Rome La Sapienza, I

Giacomo Pucci, University of Perugia, I

Marcello Rattazzi, University of Padua, I 

Michela Relucenti, University of Rome La Sapienza, I

Gian Paolo Rossi, University of Padua, I 

Massimo Rossi, University of Rome La Sapienza, I

Giacomo Rossitto, University of Padua, I

Massino Salvetti, University of Brescia, I

Susanna Sciomer, University of Rome La Sapienza, I

Teresa M. Seccia (Vice-Coordinator), University of Padua, I

Roberto Stramare, University of Padua, I

Giuliano Tocci, University of Rome La Sapienza, I

Danilo Toni, University of Rome La Sapienza, I

Matthias Barton, University of Zurich, CH

Ariela Benigni, Istituto Mario Negri, I

Ana Briones Alonso, Universidad Autonoma de Madrid, E

Christian Delles, University of glasgow, UK

Tilman Hackeng, CARIM, NL

Abraham Kroon, CARIM, NL

Francesca Mallamaci, CNR, I

Marko Poglitsch, Attoquant Diagnostics, A

Koen Reesink, Maastricht University, NL

Leon Schurgers, CARIM, NL

Ulrike Muscha Steckelings, Syddansk Universitet, DN

Maria Christina Zennaro, INSERM, F


  PhD Students


Francesca Gioco

Eugenia Guerzoni

Martino Pengo


Cycle XXIX

Marilina Citton

Verdiana Ravarotto

Paul Emmanuel Vanderriele

Giovanni Viel



Scarpa Riccardo

Bisogni Valeria

Prisco Selene

Citoni Barbara

Torresan Francesca

Piazza Maria

Saracino Vincenza



Calvez Valentin

Cesario Vincenzo 

Concistrè Antonio 

Crimì Filippo

Miceli Francesca

Zingaretti Viviana



Caputo Ilaria

Nicolini Ettore

Presta Vivianne

Schiavone Donatella

Shagjaa Tungalagtamir



Cycle XXXV

Adducci Carmen

Alfarano Maria

Bressan Alessandro

Duraku Muja Eva

Figliuzzi Ilaria

Letteri Federica

Pata Francesco

Risitano Angela

Sanga Viola

Spimpolo Alessandro

Tartaglione Lida



Ajjour Hala

Byiringiro Clement

Circosta Francesco

Giovanardi Francesco

Mariani Marco Valerio

Neccia Matteo 

Petraglia Luca

Tini Melato Giacomo



Bagordo Domenico

Kohlscheen Eva

Pintus Giovanni

Zanon Chiara



Bertoli Eleonora

Cabrelle Giulio

Costanzo Maria Ludovica

Scoccia Gianmarco

Zanella Luca


Weekly Meetings


The Weekly Meetings (open only to faculty and PhD students) are held every Wednesday at 08:15 a.m. During the meeting each PhD student will discuss his/her project and share the ongoing results with the Faculty members and other PhD students.


Journal Club

The Journal Club are held every Friday at 08:15 a.m. and are open to attendees. At each Journal Club recent papers focussed on experimental or clinical aspects of hypertension or cardiovascular diseases at large are presented by a PhD student and counter-discussed by another PhD student under the supervision of the Coordinator or another Faculty member.

  Recent Publications

Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing Adenoma, Letter to the Editor.

Schiavone D, Iacobone M, Rossi GPJournal of Clinical Hypertension - 2022. PMID: 34967112 - DOI: 10.1111/jch.14416 - IF: 3.738


Identification of glucocorticoid-related molecular signature by whole blood methylome analysis.

Armignacco R, Anne Jouinot A, Bouys L, Septier A, Lartigue T, Neou M, Gaspar C, Karine Perlemoine K, Braun L, Riester A, Bonnet-Serrano F, Blanchard A, Amar L, Scaroni C, Ceccato F, Rossi GP, Williams TA, Larsen C, Allassonnière S, Zennaro MC, Beuschlein F, Reincke M, Bertherat J, Assié G. European Journal of Endocrinology - 2022. PMID: 34914631 - DOI: 10.1530/EJE-21-0907 - IF: 6.664


Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism.

Rossi GP, Crimì F, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LS, Vonend O, Willenberg H, Fuller PJ, Yang J, Yong Nian Chee N, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Wu VC, Kratka Z, Barbiero G, Battistel M, Seccia TM. Hypertension - 2022. PMID: 34878892 - DOI: 10.1161/HYPERTENSIONAHA.121.18284 - IF: 10.190


Modern Management of Hypertensive Emergencies.

Rossi GP, Rossitto G, Maifredini C, Barchitta A, Bettella A, Cerruti L, Latella R, Ruzza L, Sabini B, Vigolo, Seccia TM. High Blood Pressure & Cardiovascular Prevention - 2022. PMID: 34813055 - DOI: 10.1007/s40292-021-00487-1

Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism, Letter to the Editor.

Rossi GP, Rossitto G. Journal of Clinical Endocrinology & Metabolism - 2022. PMID: 34610120 - DOI: 10.1210/clinem/dgab717 - IF: 5.958


Neuropeptide G Protein-Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back.

Lenzini L, Caroccia B, Seccia TM, Rossi GP. Endocrine Reviews - 2022. PMID: 35436330 - DOI: 10.1210/endrev/bnac011 - IF: 19.871


Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.

Caputo I, Caroccia B, Frasson I, Poggio E, Zamberlan S, Morpurgo M, Seccia TM, Calì T, Brini M, Richter SN, Rossi GP. International Journal Of Molecular Sciences - 2022. PMID: 35563515 - DOI: 10.3390/ijms23095125 - IF: 6.208


Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review.

Sanga V, Rossitto G, Seccia TM, Rossi GP. Hypertension - 2022. PMID: 35686552 - DOI: 10.1161/HYPERTENSIONAHA.121.18858 - IF: 9.897


Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study.

Rossi GP, Rossitto G. Hypertension - 2022. PMID: 35947644 - DOI: 10.1161/HYPERTENSIONAHA.122.19662 - IF: 9.897


Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.

Pommer G, Pamporaki C, Peitzsch M, Remde H, Deutschbein T, Nölting S, Müller LM, Braun L, Gruber S, Pecori A, Hampson S, Davies E, Stell A, Rossi GP, Lenzini L, Ceccato F, Timmers HJLM, Deinum J, Amar L, Blanchard A, Baron S, Fassnacht M, Dobrowolski P, Januszewicz A, Zennaro MC, Prejbisz A, Eisenhofer G. Journal of Clinical Endocrinology & Metabolism - 2022. PMID: 35767279  - DOI: 10.1210/clinem/dgac390 – IF: 6.134


Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios.

Reel S, Reel PS, Erlic Z, Amar L, Pecori A, Larsen CK, Tetti M, Pamporaki C, Prehn C, Adamski J, Prejbisz A, Ceccato F, Scaroni C, Kroiss M, Dennedy MC, Deinum J, Eisenhofer G, Langton K, Mulatero P, Reincke M, Rossi GP, Lenzini L, Davies E, Gimenez-Roqueplo AP, Assié G, Blanchard A, Zennaro MC, Beuschlein F, Jefferson ER. Metabolites - 2022. PMID: 36005627 - DOI: 10.3390/metabo12080755 - IF: 5.581


Identification of risk loci for primary aldosteronism in genome-wide association studies.

Le Floch E, Cosentino T, Larsen CK, Beuschlein F, Reincke M, Amar L, Rossi GP, De Sousa K, Baron S, Chantalat S, Saintpierre B, Lenzini L, Frouin A, Giscos-Douriez I, Ferey M, Abdellatif AB, Meatchi T, Empana JP, Jouven X, Gieger C, Waldenberger M, Peters A, Cusi D, Salvi E, Meneton P, Touvier M, Deschasaux M, Druesne-Pecollo N, Boulkroun S, Fernandes-Rosa FL, Deleuze JF, Jeunemaitre X, Zennaro MC. Nature Communications - 2022. PMID: 36057693 - DOI: 10.1038/s41467-022-32896-8 - IF: 17.694


Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors.

Rossi GP, Barton M, Dhaunc N, Rizzoni D, Seccia TM.  Journal of Hypertension - 2022 DOI:10.1097/HJH.0000000000003314 - IF: 4.776


Whole blood methylome-derived features to discriminate endocrine hypertension.

Armignacco R, Reel PS, Reel S, Jouinot A, Septier A, Gaspar C, Perlemoine K, Larsen CK, Bouys L, Braun L, Riester A, Kroiss M, Bonnet-Serrano F, Amar L, Blanchard A, Gimenez-Roqueplo AP, Prejbisz A, Januszewicz A, Dobrowolski P, Davies E, MacKenzie SM, Rossi GP, Lenzini L, Ceccato F, Scaroni C, Mulatero P, Williams TA, Pecori A, Monticone S, Beuschlein F, Reincke M, Zennaro MC, Bertherat J, Jefferson E, Assié G. Clinical Epigenetics - 2022. PMID: 36329530 - DOI: 10.1186/s13148-022-01347-y - IF: 7.28


Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study.

Reel PS, Reel S, van Kralingen JC, Langton K, Lang K, Erlic Z, Larsen CK, Amar L, Pamporaki C, Mulatero P, Blanchard A, Kabat M, Robertson S, MacKenzie SM, Taylor AE, Peitzsch M, Ceccato F, Scaroni C, Reincke M, Kroiss M, Dennedy MC, Pecori A, Monticone S, Deinum J, Rossi GP, Lenzini L, McClure JD, Nind T, Riddell A, Stell A, Cole C, Sudano I, Prehn C, Adamski J, Gimenez-Roqueplo AP, Assié G, Arlt W, Beuschlein F, Eisenhofer G, Davies E, Zennaro MC, Jefferson E. Ebiomedicine - 2022. PMID: 36179553 - DOI: 10.1016/j.ebiom.2022.104276 - IF: 11.205


Peptidergic G Protein-Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back.

Lenzini L, Caroccia B, Seccia TM, Rossi GP. Endocrine Reviews - 2022. PMID: 35436330 - DOI: 10.1210/endrev/bnac011 - IF: 25.261


Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma.

Piazza M, Hanssen NMJ, Scheijen JLJM, Vd Waarenburg M, Caroccia B, Seccia TM, Stehouwer CDA, Rossi GP, Schalkwijk CG. Journal of Human Hypertension - 2022. PMID: 36418426 - DOI: 10.1038/s41371-022-00773-y - IF: 2.877


Skin Hyperpigmentation Due to Post-Surgical Adrenal Insufficiency Regressed with the Dexamethasone Treatment.

Shagjaa T, Sanga V, Rossi GP. Journal of Clinical Medicine - 2022. PMID: 36143026 - DOI: 10.3390/jcm11185379 - IF: 4.964


Aldosterone and cortisol synthesis regulation by angiotensin-(1-7) and angiotensin-converting enzyme 2 in the human adrenal cortex.

Caroccia B, Vanderriele PE, Seccia TM, Piazza M, Lenzini L, Prisco S, Torresan F, Domening O, Iacobone M, Poglitsch M, Rossi GP.J Hypertens. 2021 Mar 1. doi: 10.1097/HJH.0000000000002816. Online ahead of print.PMID: 33657582


The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.

Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, Ferri C, Giacchetti G, Grassi G, Letizia C, Maccario M, Mallamaci F, Maiolino G, Manfellotto D, Minuz P, Monticone S, Morganti A, Muiesan ML, Mulatero P, Negro A, Parati G, Pengo MF, Petramala L, Pizzolo F, Rizzoni D, Rossitto G, Veglio F, Seccia TM.Int J Cardiol Hypertens. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029. eCollection 2020 Jun.PMID: 33447758 Free PMC article.


Familial hyperaldosteronism type 1 and pregnancy: successful treatment with low dose dexamethasone.

Sanga V, Lenzini L, Seccia TM, Rossi GP.Blood Press. 2021 Jan 4:1-5. doi: 10.1080/08037051.2020.1863771. Online ahead of print.PMID: 33390031


Aldosterone synthase inhibitors for cardiovascular diseases: A comprehensive review of preclinical, clinical and in silico data.

Lenzini L, Zanotti G, Bonchio M, Rossi GP.Pharmacol Res. 2021 Jan;163:105332. doi: 10.1016/j.phrs.2020.105332. Epub 2020 Dec 1.PMID: 33271294.


Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension.

Rossi GP, Bisogni V, Rossitto G, Maiolino G, Cesari M, Zhu R, Seccia TM.High Blood Press Cardiovasc Prev. 2020 Dec;27(6):547-560. doi: 10.1007/s40292-020-00415-9. Epub 2020 Nov 7.PMID: 33159664 Free PMC article.


High Sodium Intake, Glomerular Hyperfiltration and Protein Catabolism in Patients with Essential Hypertension.

Rossitto G, Maiolino G, Lerco S, Ceolotto G, Blackburn G, Mary S, Antonelli G, Berton C, Bisogni V, Cesari M, Seccia TM, Lenzini L, Pinato A, Montezano A, Touyz RM, Petrie MC, Daly R, Welsh P, Plebani M, Rossi GP, Delles C.Cardiovasc Res. 2020 Jul 16:cvaa205. doi: 10.1093/cvr/cvaa205. Online ahead of print.PMID: 33053160


Primary aldosteronism in elderly, old, and very old patients.

Cesari M, Seccia TM, Maiolino G, Rossi GP.J Hum Hypertens. 2020 Dec;34(12):807-813. doi: 10.1038/s41371-020-00395-2. Epub 2020 Sep 14.PMID: 32929132 .


Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J.J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.PMID: 32890264


Resolution of drug-resistant hypertension by adrenal vein sampling-guided adrenalectomy: a proof-of-concept study.

Torresan F, Rossitto G, Bisogni V, Lerco S, Maiolino G, Cesari M, Zhu R, Iacobone M, Seccia TM, Rossi GP.Clin Sci (Lond). 2020 Jun 12;134(11):1265-1278. doi: 10.1042/CS20200340.PMID: 32452518


Disease monitoring of Primary Aldosteronism.

Rossi GP, Cesari M, Lenzini L, Seccia TM.Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101417. doi: 10.1016/j.beem.2020.101417. Epub 2020 Mar 10.PMID: 32336665.


Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J.J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.PMID: 32890264


Disease monitoring of Primary Aldosteronism.

Rossi GP, Cesari M, Lenzini L, Seccia TM.Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101417. doi: 10.1016/j.beem.2020.101417. Epub 2020 Mar 10.PMID: 32336665.


Vitamin D supplementation: a novel therapy for aldosteronism?

Rossi GP, Lenzini L.Nat Rev Endocrinol. 2020 Jun;16(6):303-304. doi: 10.1038/s41574-020-0359-3.PMID: 32286517.


Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.

Rossi GP, Sanga V, Barton M.Elife. 2020 Apr 6;9:e57278. doi: 10.7554/eLife.57278.PMID: 32250244 Free PMC article.


The cardiovascular consequences of hyperaldosteronism.

Rossi GP, Seccia TM, Maiolino G, Cesari M.Ann Endocrinol (Paris). 2020 Feb 28:S0003-4266(20)30029-9. doi: 10.1016/j.ando.2020.02.006. Online ahead of print.PMID: 32192789


Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.

Rossi GP, Ceolotto G, Rossitto G, Maiolino G, Cesari M, Seccia TM.J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgaa080. doi: 10.1210/clinem/dgaa080.PMID: 32067030


Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study.

Seccia TM, Letizia C, Muiesan ML, Lerco S, Cesari M, Bisogni V, Petramala L, Maiolino G, Volpin R, Rossi GP.J Hypertens. 2020 Feb;38(2):332-339. doi: 10.1097/HJH.0000000000002250.PMID: 31834121


Primary Aldosteronism: JACC State-of-the-Art Review.

Rossi GP.J Am Coll Cardiol. 2019 Dec 3;74(22):2799-2811. doi: 10.1016/j.jacc.2019.09.057.PMID: 31779795.


Arterial Hypertension, Aldosterone, and Atrial Fibrillation.

Seccia TM, Caroccia B, Maiolino G, Cesari M, Rossi GP.Curr Hypertens Rep. 2019 Nov 18;21(12):94. doi: 10.1007/s11906-019-1001-4.PMID: 31741119.


Heterogenous Responses to Cosyntropin in Primary Aldosteronism.

Rossi GP.J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz133. doi: 10.1210/clinem/dgz133.PMID: 31665321 No abstract available.


Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution.

Battistel M, Ceolotto G, Barbiero G, Rossitto G, Rossi GP.J Hypertens. 2018 Sep;36(9):1942-1944. doi: 10.1097/HJH.0000000000001827.PMID: 30192309 No abstract available.


The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Seccia TM, Caroccia B, Gomez-Sanchez EP, Gomez-Sanchez CE, Rossi GP.Endocr Rev. 2018 Dec 1;39(6):1029-1056. doi: 10.1210/er.2018-00060.PMID: 30007283 Free PMC article. Review.


Does angiotensin II regulate parathyroid hormone secretion or not?

Rossi GP, Prisco S.Clin Endocrinol (Oxf). 2018 Nov;89(5):568-569. doi: 10.1111/cen.13798. Epub 2018 Jul 11.PMID: 29947100 No abstract available.


Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations.

Ravarotto V, Loffing J, Loffing-Cueni D, Heidemeyer M, Pagnin E, Calò LA, Rossi GP.Hypertens Res. 2018 Aug;41(8):578-588. doi: 10.1038/s41440-018-0061-1. Epub 2018 Jun 20.PMID: 29925901


Saga of Familial Hyperaldosteronism: Yet a New Channel.

Lenzini L, Prisco S, Caroccia B, Rossi GP.Hypertension. 2018 Jun;71(6):1010-1014. doi: 10.1161/HYPERTENSIONAHA.118.11150. Epub 2018 May 7.PMID: 29735637 Review. No abstract available.


Mineralocorticoid receptor antagonists: time of repositioning them in the treatment of arterial hypertension.

Rossi GP.J Hypertens. 2018 May;36(5):1015-1018. doi: 10.1097/HJH.0000000000001686.PMID: 29578956 No abstract available.


Cure With Cryoablation of Arterial Hypertension Due to a Renin-Producing Tumor.

Maiolino G, Battistel M, Barbiero G, Bisogni V, Rossi GP.Am J Hypertens. 2018 Apr 13;31(5):537-540. doi: 10.1093/ajh/hpx213.PMID: 29522074


Update in adrenal venous sampling for primary aldosteronism.

Rossi GP.Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):160-171. doi: 10.1097/MED.0000000000000407.PMID: 29521660 Review.


Management of a Pregnant Woman With Fibromuscular Dysplasia.

Berra E, Dominiczak AF, Touyz RM, Pierard S, Hammer F, Rossi GP, Micali RG, Staessen JA, Bursztyn M, Kahan T, Persu A.Hypertension. 2018 Apr;71(4):540-547. doi: 10.1161/HYPERTENSIONAHA.118.10819. Epub 2018 Feb 26.PMID: 29483231 No abstract available.


Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.

Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators.Hypertension. 2018 Apr;71(4):585-591. doi: 10.1161/HYPERTENSIONAHA.117.10596. Epub 2018 Feb 26.PMID: 29483224


Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea.

Pengo MF, Ratneswaran C, Berry M, Kent BD, Kohler M, Rossi GP, Steier J.J Clin Hypertens (Greenwich). 2016 Nov;18(11):1180-1184. doi: 10.1111/jch.12845. Epub 2016 Jun 1.PMID: 27251875


Adrenal vein sampling versus CT scanning in primary aldosteronism.

Funder JW, Rossi GP.Lancet Diabetes Endocrinol. 2016 Nov;4(11):886. doi: 10.1016/S2213-8587(16)30240-6.PMID: 27793316 No abstract available.


Recent advances in the diagnosis and management of obstructive sleep apnea.

Vianello A, Bisogni V, Rinaldo C, Gallan F, Maiolino G, Braccioni F, Guarda-Nardini L, Molena B, Rossi GP, Marchese-Ragona R; Padova Sleep Apnea Study Group.Minerva Med. 2016 Dec;107(6):437-451. Epub 2016 Sep 13.PMID: 27625198 Review.


Estrogen Signaling in the Adrenal Cortex: Implications for Blood Pressure Sex Differences.

Caroccia B, Seccia TM, Barton M, Rossi GP.Hypertension. 2016 Oct;68(4):840-8. doi: 10.1161/HYPERTENSIONAHA.116.07660.PMID: 27600178 Review. No abstract available.


Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism.

Rossitto G, Miotto D, Battistel M, Barbiero G, Maiolino G, Bisogni V, Sanga V, Rossi GP.J Hypertens. 2016 Nov;34(11):2258-65. doi: 10.1097/HJH.0000000000001082.PMID: 27512976


Obituary: Cesare Dal Palù MD 20-01-1923-18-01-2016.

Pessina AC, Rossi GP.J Hypertens. 2016 May;34(5):1022. doi: 10.1097/hjh.0000000000000900.PMID: 27482560 No abstract available.


Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.

Seccia TM, Caroccia B, Gioco F, Piazza M, Buccella V, Guidolin D, Guerzoni E, Montini B, Petrelli L, Pagnin E, Ravarotto V, Belloni AS, Calò LA, Rossi GP.J Am Heart Assoc. 2016 Jul 21;5(7):e003888. doi: 10.1161/JAHA.116.003888.PMID: 27444511 Free PMC article.


Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea.

Pengo MF, Xiao S, Ratneswaran C, Reed K, Shah N, Chen T, Douiri A, Hart N, Luo Y, Rafferty GF, Rossi GP, Williams A, Polkey MI, Moxham J, Steier J.Thorax. 2016 Oct;71(10):923-31. doi: 10.1136/thoraxjnl-2016-208691. Epub 2016 Jul 19.PMID: 27435610 Free PMC article. Clinical Trial.


Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.

Cesari M, Letizia C, Angeli P, Sciomer S, Rosi S, Rossi GP.Circ Cardiovasc Imaging. 2016 Jun;9(6):e004815. doi: 10.1161/CIRCIMAGING.116.004815.PMID: 27307552

  News and Events 2023

The 2023 Winter School of the PhD Course in Arterial Hypertension and Vascular Biology (ARHYVAB), which will take place in Brixen from March 13th to 17th, 2023.


The School is open to the PhD students of the MINDSHIFT Program, the PhD students of the International PhD Course ARHYVAB, residents in Endocrinology, Internal Medicine and Emergency, and also to the students in Medicine.

We include more than 20 talks and lectures taken by top experts in different fields from EU and US, and interactive sessions aimed at discussing the pathophysiology and treatment of cardiovascular diseases. 


The Winter School is part of the formal activities of the ARHYVAB and, therefore, all PhD should participate to the event.


The Venue will be:

Gruner Baum Hotels

Stufels 11 /Via Stufles 11

39042 Brixen /Bressanone, BZ, Italy


Room reservation. Accommodation can be arranged by yourself. Rooms are available at the Gruner Baum and other hotels in Brixen. For cheaper accommodation, please contact the Youth Hotel (

Please feel free to send this mail to the PhD of other Courses, residents and all could be interested to the event.

We look forward to seeing you


31th European Meeting on Hypertension and Cardiovascular Prevention,

June 17-20, Athens